![](https://endpts.com/wp-content/uploads/2022/08/David-Mussafer-chairman-of-Advent-International.jpg)
David Mussafer, chairman of Advent International
Advent to sell stake in manufacturer and drug developer in a deal worth over $1B — report
After almost three years of investment, private equity firm Advent International may look to sell its part in Bioduro-Sundia.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.